Six hospitals in Indiana and Alabama agreed to pay the government more than $8 million to settle allegations that they submitted false claims to Medicare, the US Department of Justice announced September 29, 2009.
The settlements resolve allegations that from 2002 to 2008, the hospitals overbilled Medicare for kyphoplasty, a minimally invasive procedure used to treat spinal fractures due to osteoporosis.
The government contends the hospitals performed the procedure on an inpatient basis to increase their Medicare billings even though kyphoplasty in many cases can be performed safely as outpatient surgery.
The Indiana hospitals include St Francis Hospital in Beech Grove ($3.2 million), Deaconess Hospital in Evansville ($2.1 million), and St John’s Health System in Anderson ($826,000).
The Alabama hospitals are St Vincent’s East Hospital ($1.5 million) and St Vincent’s Birmingham Hospital ($423,000), both in Birmingham, and Providence Hospital in Mobile ($382,000).
Some 100 hospitals are said to be under investigation.
The settlements follow the government’s $2.3 million settlement with 3 Minnesota hospitals in May 2009 for allegedly fraudulent kyphoplasty claims.
In 2008, the government reached a $75 million settlement with Medtronic Spine LLC, which now owns Kyphon, the company that developed the procedure. The company did not admit wrong-doing.
St Francis said in a statement that it cooperated fully with the government. It said the focus of the investigation was on “the lack of documentation to support the treatment in an inpatient setting.”
St Vincent’s Health System also said it had cooperated in the investigation, admitted no liability, and settled to avoid further litigation costs. It said the investigation focused on documentation, and “there were no concerns about the medical necessity of the kyphoplasty itself for any patients.”
St John’s Health System issued a similar statement.
The settlements stem from a whistleblower lawsuit filed in 2006 by 2 former Kyphon employees, Craig Patrick, a former reimbursement manager, and Charles M. Bates, a former regional sales manager.
The suit alleged that Kyphon conducted a fraudulent marketing campaign that induced hospitals to bill Medicare for kyphoplasty as an inpatient procedure.
Billings for unnecessary inpatient admissions are considered false claims under the False Claims Act.
Among allegations were that Kyphon representatives met with hospital personnel to explain how to code and bill charges to ensure payment under the DRGs.
Court documents also said sales reps would be present in the OR during kyphoplasty and were taught how to prompt staff and physicians to order inpatient admissions (July 2009 OR Manager).
The whistleblowers will receive about $1.4 million as their share of the settlements.